MedTrace Logo

Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media

NCT00195611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3293

Last updated 2010-06-29

No results posted yet for this study

Summary

The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.

Conditions

  • Otitis Media
  • Otitis Media With Effusion
  • Pneumococcal Infections

Interventions

DRUG

Prevenar

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer

Eligibility

Min Age
6 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00195611 on ClinicalTrials.gov